A Study on Efficacy of Verhoeff Van Gieson Elastic Stain and CD34 Immunohistochemistry in Identification of Extramural Vascular Invasion in Colorectal Cancers
DOI:
https://doi.org/10.21276/apalm.3715Keywords:
colorectal carcinoma, immunohistochemistry, elastic fibres, hematoxylinAbstract
Background: Colorectal cancer (CRC) is the third most common malignancy worldwide and the second leading cause of cancer-related deaths, mainly due to late-stage diagnosis and recurrence. Lymphovascular invasion (LVI), particularly extramural vascular invasion (EMVI), is a strong prognostic marker linked to metastasis and poorer survival outcomes. However, EMVI detection is often underreported due to variability in diagnostic techniques, making accurate identification crucial for guiding adjuvant therapy decisions. This study aims to compare the efficacy of hematoxylin and eosin (H&E) staining, Verhoeff Van Gieson (VVG) elastic staining, and CD34 immunohistochemistry (IHC) in detecting EMVI in colorectal cancer specimens.
Methods: This is a cross-sectional study of 72 colorectal cancer patients conducted at a tertiary referral center in Kerala, South India, over a period of 18 months. EMVI was assessed using H&E, VVG, and CD34 stains, and detection rates were compared using SPSS 23.0 version.
Result: H&E staining identified EMVI in 10 cases (14%), VVG in 15 cases (21%), and CD34 IHC in 7 cases (9.7%), with significant differences between methods. VVG staining had the highest detection rate and was significantly associated with lymph node metastasis (p=0.024) and advanced AJCC stages (p=0.017).
Conclusion: VVG elastic staining enhances EMVI detection in colorectal cancer compared to H&E. The use of CD34 IHC, while less effective and more resource-intensive, is not recommended for routine EMVI detection due to its lower sensitivity and technical complexity.
References
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. doi:10.3322/caac.21834
2. Hossain MdS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A, et al. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers. 2022 Mar 29;14(7):1732. doi:10.3390/cancers14071732
3. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przegląd Gastroenterol. 2019;14(2):89–103. DOI: 10.5114/pg.2018.81072
4. McClelland D, Murray GI. A Comprehensive Study of Extramural Venous Invasion in Colorectal Cancer. PLoS ONE. 2015 Dec 15;10(12):e0144987. DOI: 10.1371/journal.pone.0144987
5. Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, et al. Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum. Arch Pathol Lab Med. 2009 Oct 1;133(10):1539–51. DOI: 10.5858/133.10.1539
6. Dawson H, Kirsch R, Driman DK, Messenger DE, Assarzadegan N, Riddell RH. Optimizing the Detection of Venous Invasion in Colorectal Cancer: The Ontario, Canada, Experience and Beyond. Front Oncol. 2015 Jan 5;4. DOI: 10.3389/fonc.2014.00354
7. Odze and Goldblum Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. 4th ed. Elsevier eLibrary.
8. Duan K, Chow B, Tsui W, Elliot C, Sari A, Shivji S, et al. Impact of tissue sampling on detection of venous invasion in colorectal cancer: a prospective analysis. Histopathology. 2023;83(6):891–902. doi:10.1111/his.15030
9. Howlett CJ, Tweedie EJ, Driman DK. Use of an elastic stain to show venous invasion in colorectal carcinoma: a simple technique for detection of an important prognostic factor. J Clin Pathol. 2009 Nov 1;62(11):1021–5. doi:10.1136/jcp.2009.065615
10. Amritha PS, Mallya V, Khurana N, Lal P. Prognostic Significance of Intramural and Extramural Lymphovascular Invasion in Colorectal Carcinoma. Indian J Colo-Rectal Surg. 2022 Dec;5(3):47–51. doi:10.4103/ijcs.ijcs_22_21
11. Messenger DE, Driman DK, Kirsch R. Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome. Hum Pathol. 2012 Jul;43(7):965–73. doi:10.1016/j.humpath.2011.11.015
12. Kirsch R, Messenger DE, Riddell RH, Pollett A, Cook M, Al-Haddad S, et al. Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists. Am J Surg Pathol. 2013 Feb;37(2):200–10. doi:10.1097/PAS.0b013e31826a92cd
13. Hwang C, Lee S, Kim A, Kim YG, Ahn SJ, Park DY. Venous Invasion in Colorectal Cancer: Impact of Morphologic Findings on Detection Rate. Cancer Res Treat Off J Korean Cancer Assoc. 2016 Oct;48(4):1222–8.
14. Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer. 2012 Feb 1;118(3):628–38. doi:10.1097/PAS.0b013e31826a92cd
15. Duduyemi B, Andoh D, Adankwah E, Nyarko H, Agyemang D. The use of special stains in the detection of vascular invasion in cases of colon cancer in resource-limited settings in Africa. Ann Trop Pathol. 2020;11(1):21. doi:10.4103/atp.atp_1_20
16. Mc Entee PD, Shokuhi P, Rogers AC, Mehigan BJ, McCormick PH, Gillham CM, et al. Extramural venous invasion (EMVI) in colorectal cancer is associated with increased cancer recurrence and cancer-related death. Eur J Surg Oncol. 2022 Jul 1;48(7):1638–42. doi:10.1016/j.ejso.2022.02.013
17. Abdulkader M, Abdulla K, Rakha E, Kaye P. Routine elastic staining assists detection of vascular invasion in colorectal cancer. Histopathology. 2006;49(5):487–92.
18. Minsky B, Mies C. The clinical significance of vascular invasion in colorectal cancer. Dis Colon Rectum. 1989 Sep;32(9):794–803. doi:10.1007/BF02562132
19. Liu Q, Polydorides AD. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine. Mod Pathol Off J U S Can Acad Pathol Inc. 2020 Nov;33(11):2318–29.
20. Bogner B, Hegedûs G. The importance of elastic staining in detecting vascular invasion in colorectal carcinoma. Magy Onkol. 2009 Jul 1;53:107–13.
21. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJR, Morson BC. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology. 1981;5(2):141–63.
22. Kingston EF, Goulding H, Bateman AC. Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum. 2007 Nov;50(11):1867–72.
23. Gama H, Albuquerque R, Campos Wanderley D, Pascoal Xavier MA, Osório FMF, Couto CA, et al. CD34 immunostaining adds specificity to microvascular invasion analysis in hepatocellular carcinoma. J Hepatocell Carcinoma. 2023 Jan 22;10:91–8. doi:10.2147/JHC.S389836
24. Harris E, Lewin D, Wang H, Lauwers G, Srivastava A, Shyr Y, et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol. 2008 Dec;32(12):1816–21. doi:10.1097/PAS.0b013e3181816083
25. Leone P, Malerba E, Susca N, Favoino E, Perosa F, Brunori G, et al. Endothelial cells in tumor microenvironment: insights and perspectives. Front Immunol. 2024 Feb 15;15:1367875. doi:10.3389/fimmu.2024.1367875
26. Fan CS, Chen WS, Chen LL, Chen CC, Hsu YT, Chua KV, et al. Osteopontin–integrin engagement induces HIF-1α–TCF12-mediated endothelial-mesenchymal transition to exacerbate colorectal cancer. Oncotarget. 2017 Dec 22;9(4):4998–5015.
27. Gonzalez J, Bahmad HF, Ocejo S, Abreu A, Popp M, Gogola S, et al. The usefulness of elastin staining to detect vascular invasion in cancer. Int J Mol Sci. 2023 Oct 17;24(20):15264. doi:10.3390/ijms242015264
28. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood. 1994 Oct 15;84(8):2554–65.
29. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand Factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006 Apr 1;54(4):385–95.
30. Müller AM, Hermanns MI, Skrzynski C, Nesslinger M, Müller KM, Kirkpatrick CJ. Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol. 2002 Jun;72(3):221–9.
31. Dupas T, Rouaud T, Rouger K, Lieubeau B, Cario-Toumaniantz C, Fontaine-Pérus J, et al. Fetal muscle contains different CD34+ cell subsets that distinctly differentiate into adipogenic, angiogenic and myogenic lineages. Stem Cell Res. 2011 Nov;7(3):230–43. doi:10.1016/j.scr.2011.07.006
32. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells Dayt Ohio. 2014 Jun;32(6):1380–9.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dilsha Sidheekh, Moothiringode Chithrabanu Savithri, Sreeja Raju
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
